Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 5Leukemia, Myelomonocytic, Chronic 4Leukemia 4Anemia, Refractory, with Excess of Blasts 3Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Diseases 2Blast Crisis 2Preleukemia 1Neutropenia 1Myeloproliferative Disorders 1Anemia, Refractory 1

Interventions

liposomal amphotericin B 2Cytarabine 2lintuzumab 1isavuconazole 1Voriconazole 1Vegetables 1Moxifloxacin 1Mitoxantrone 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Idarubicin 1Filgrastim 1Etoposide 1Clofarabine 1Ciprofloxacin 1Cefepime 1Caspofungin 1Amoxicillin-Potassium Clavulanate Combination 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × lintuzumab × Myeloid × Clear all
NCT00002800 2013-07-03

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡